Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wenbin Ma

Showing results (91-100 of 416) with videos related to

Pageof 42
Sort By:
Neurosurgical Review|February 7, 2026
Elucidating the causal relationships between cerebrospinal fluid metabolites and glioblastoma insights from mendelian randomization studyChengrui Yan, Bin Wang, Guangchao Shi, et al.
Frontiers in Oncology|September 10, 2025
Predictive role of MGMT and IDH status in the efficacy of bevacizumab for high-grade glioma: a retrospective studyBai Xuexue, Yan Chengrui, Wenbin Ma, et al.
International Journal of Biological Sciences|August 11, 2023
B7-H3 in Brain Malignancies: Immunology and ImmunotherapyXiaopeng Guo, Mengqi Chang, Yu Wang, et al.
Journal of Cancer Research and Clinical Oncology|May 29, 2023
Grade scoring system reveals distinct molecular subtypes and identifies KIF20A as a novel biomarker for predicting temozolomide treatment efficiency in gliomasLiguo Ye, Shi'ao Tong, Yaning Wang, et al.
Journal of Clinical Medicine|September 9, 2022
Cytomegalovirus and Glioblastoma: A Review of the Biological Associations and Therapeutic StrategiesTianrui Yang, Delin Liu, Shiyuan Fang, et al.
Journal of Cellular and Molecular Medicine|June 19, 2019
Molecular biomarker-guided anti-angiogenic targeted therapy for malignant gliomaChengrui Yan, Jiaru Wang, Yuyan Yang, et al.
Frontiers in Oncology|September 18, 2025
Correlation between MGMT methylation and the efficacy of bevacizumab in high-grade gliomaChengrui Yan, Xuexue Bai, Chao Wu, et al.
Molecular Neurobiology|May 22, 2016
Is CD147 a New Biomarker Reflecting Histological Malignancy of Gliomas?Xiangyi Kong, Yu Wang, Congxin Dai, et al.
Medicine|March 9, 2017
Continuous dose-intense temozolomide and cisplatin in recurrent glioblastoma patientsYu Wang, Xiangyi Kong, Yi Guo, et al.
Cancer Research|October 3, 2002
Identification and characterization of mouse metastasis-suppressor KiSS1 and its G-protein-coupled receptorLewis Joe Stafford, Chunzhi Xia, Wenbin Ma, et al.
Pageof 42

Showing results (91-100 of 416) with videos related to

Sort By:
Pageof 42
Neurosurgical Review|February 7, 2026
Elucidating the causal relationships between cerebrospinal fluid metabolites and glioblastoma insights from mendelian randomization studyChengrui Yan, Bin Wang, Guangchao Shi, et al.
Frontiers in Oncology|September 10, 2025
Predictive role of MGMT and IDH status in the efficacy of bevacizumab for high-grade glioma: a retrospective studyBai Xuexue, Yan Chengrui, Wenbin Ma, et al.
International Journal of Biological Sciences|August 11, 2023
B7-H3 in Brain Malignancies: Immunology and ImmunotherapyXiaopeng Guo, Mengqi Chang, Yu Wang, et al.
Journal of Cancer Research and Clinical Oncology|May 29, 2023
Grade scoring system reveals distinct molecular subtypes and identifies KIF20A as a novel biomarker for predicting temozolomide treatment efficiency in gliomasLiguo Ye, Shi'ao Tong, Yaning Wang, et al.
Journal of Clinical Medicine|September 9, 2022
Cytomegalovirus and Glioblastoma: A Review of the Biological Associations and Therapeutic StrategiesTianrui Yang, Delin Liu, Shiyuan Fang, et al.
Journal of Cellular and Molecular Medicine|June 19, 2019
Molecular biomarker-guided anti-angiogenic targeted therapy for malignant gliomaChengrui Yan, Jiaru Wang, Yuyan Yang, et al.
Frontiers in Oncology|September 18, 2025
Correlation between MGMT methylation and the efficacy of bevacizumab in high-grade gliomaChengrui Yan, Xuexue Bai, Chao Wu, et al.
Molecular Neurobiology|May 22, 2016
Is CD147 a New Biomarker Reflecting Histological Malignancy of Gliomas?Xiangyi Kong, Yu Wang, Congxin Dai, et al.
Medicine|March 9, 2017
Continuous dose-intense temozolomide and cisplatin in recurrent glioblastoma patientsYu Wang, Xiangyi Kong, Yi Guo, et al.
Cancer Research|October 3, 2002
Identification and characterization of mouse metastasis-suppressor KiSS1 and its G-protein-coupled receptorLewis Joe Stafford, Chunzhi Xia, Wenbin Ma, et al.
Pageof 42